Trial · NCT00436605
Adverse events21
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 21
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fatigue | General disorders | Treatment (Kinase Inhibitor Therapy) | 30 | 39 | |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Treatment (Kinase Inhibitor Therapy) | 27 | 39 | |
| other | Pleural Effusion | Respiratory, thoracic and mediastinal disorders | Treatment (Kinase Inhibitor Therapy) | 14 | 39 | |
| other | Nausea | Gastrointestinal disorders | Treatment (Kinase Inhibitor Therapy) | 26 | 39 | |
| other | Emesis | Gastrointestinal disorders | Treatment (Kinase Inhibitor Therapy) | 9 | 39 | |
| other | Diarrhea | Gastrointestinal disorders | Treatment (Kinase Inhibitor Therapy) | 14 | 39 | |
| other | Weight Loss | General disorders | Treatment (Kinase Inhibitor Therapy) | 8 | 39 | |
| other | Rash | Skin and subcutaneous tissue disorders | Treatment (Kinase Inhibitor Therapy) | 17 | 39 | |
| other | Pruritis | Skin and subcutaneous tissue disorders | Treatment (Kinase Inhibitor Therapy) | 7 | 39 | |
| other | Anorexia | General disorders | Treatment (Kinase Inhibitor Therapy) | 23 | 39 | |
| other | Xerostomia | General disorders | Treatment (Kinase Inhibitor Therapy) | 13 | 39 | |
| other | Heartburn | Gastrointestinal disorders | Treatment (Kinase Inhibitor Therapy) | 6 | 39 | |
| other | Taste Alternation | Gastrointestinal disorders | Treatment (Kinase Inhibitor Therapy) | 8 | 39 | |
| other | Edema | Vascular disorders | Treatment (Kinase Inhibitor Therapy) | 5 | 39 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Treatment (Kinase Inhibitor Therapy) | 13 | 39 | |
| serious | Fatigue | General disorders | Treatment (Kinase Inhibitor Therapy) | 5 | 39 | |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Treatment (Kinase Inhibitor Therapy) | 4 | 39 | |
| serious | Pleural Effusion | Respiratory, thoracic and mediastinal disorders | Treatment (Kinase Inhibitor Therapy) | 3 | 39 | |
| serious | Nausea | Gastrointestinal disorders | Treatment (Kinase Inhibitor Therapy) | 3 | 39 | |
| serious | Diarrhea | Gastrointestinal disorders | Treatment (Kinase Inhibitor Therapy) | 2 | 39 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00436605/events